RE: Question28 May 2021 17:37
26th Feb - Successful completion of GBP25 million Fundraise.
“The net proceeds of the Transaction, which remains subject, inter alia, to the passing of the Fundraising Resolutions at the General Meeting to be convened for on or around 18 March 2021, will be used to finance the launch of Accrufer(R) in the US which the Directors believe has the potential to generate significant returns for Shield's shareholders.”